nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Pazopanib—kidney cancer	0.00833	0.436	CbGbCtD
Rizatriptan—CYP1A2—Erlotinib—kidney cancer	0.00594	0.311	CbGbCtD
Rizatriptan—CYP1A2—Sorafenib—kidney cancer	0.00483	0.253	CbGbCtD
Rizatriptan—Melatonin—CYP1A1—kidney cancer	0.00105	0.569	CrCbGaD
Rizatriptan—Sumatriptan—ABCB1—kidney cancer	0.000795	0.431	CrCbGaD
Rizatriptan—Hypersensitivity—Sunitinib—kidney cancer	0.0006	0.000646	CcSEcCtD
Rizatriptan—Decreased appetite—Vincristine—kidney cancer	0.000599	0.000644	CcSEcCtD
Rizatriptan—Pruritus—Sorafenib—kidney cancer	0.000599	0.000644	CcSEcCtD
Rizatriptan—Vomiting—Erlotinib—kidney cancer	0.000598	0.000644	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000596	0.000641	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Vincristine—kidney cancer	0.000595	0.00064	CcSEcCtD
Rizatriptan—Fatigue—Vincristine—kidney cancer	0.000594	0.000639	CcSEcCtD
Rizatriptan—Rash—Erlotinib—kidney cancer	0.000593	0.000638	CcSEcCtD
Rizatriptan—Dermatitis—Erlotinib—kidney cancer	0.000593	0.000638	CcSEcCtD
Rizatriptan—Palpitations—Paclitaxel—kidney cancer	0.000593	0.000638	CcSEcCtD
Rizatriptan—Insomnia—Gemcitabine—kidney cancer	0.000591	0.000636	CcSEcCtD
Rizatriptan—Headache—Erlotinib—kidney cancer	0.00059	0.000634	CcSEcCtD
Rizatriptan—Tinnitus—Capecitabine—kidney cancer	0.000589	0.000634	CcSEcCtD
Rizatriptan—Loss of consciousness—Paclitaxel—kidney cancer	0.000589	0.000634	CcSEcCtD
Rizatriptan—Pain—Vincristine—kidney cancer	0.000589	0.000634	CcSEcCtD
Rizatriptan—Constipation—Vincristine—kidney cancer	0.000589	0.000634	CcSEcCtD
Rizatriptan—Osteoarthritis—Doxorubicin—kidney cancer	0.000589	0.000634	CcSEcCtD
Rizatriptan—Paraesthesia—Gemcitabine—kidney cancer	0.000587	0.000631	CcSEcCtD
Rizatriptan—Flushing—Capecitabine—kidney cancer	0.000587	0.000631	CcSEcCtD
Rizatriptan—Cough—Paclitaxel—kidney cancer	0.000585	0.00063	CcSEcCtD
Rizatriptan—Asthenia—Sunitinib—kidney cancer	0.000585	0.000629	CcSEcCtD
Rizatriptan—Dyspnoea—Gemcitabine—kidney cancer	0.000583	0.000627	CcSEcCtD
Rizatriptan—Nausea—Vinblastine—kidney cancer	0.000582	0.000626	CcSEcCtD
Rizatriptan—Somnolence—Gemcitabine—kidney cancer	0.000581	0.000625	CcSEcCtD
Rizatriptan—Convulsion—Paclitaxel—kidney cancer	0.000581	0.000625	CcSEcCtD
Rizatriptan—Nausea—Everolimus—kidney cancer	0.000579	0.000623	CcSEcCtD
Rizatriptan—Diarrhoea—Sorafenib—kidney cancer	0.000579	0.000623	CcSEcCtD
Rizatriptan—Hypertension—Paclitaxel—kidney cancer	0.000579	0.000623	CcSEcCtD
Rizatriptan—Pruritus—Sunitinib—kidney cancer	0.000576	0.00062	CcSEcCtD
Rizatriptan—Angiopathy—Capecitabine—kidney cancer	0.000574	0.000617	CcSEcCtD
Rizatriptan—Chest pain—Paclitaxel—kidney cancer	0.000571	0.000614	CcSEcCtD
Rizatriptan—Arthralgia—Paclitaxel—kidney cancer	0.000571	0.000614	CcSEcCtD
Rizatriptan—Myalgia—Paclitaxel—kidney cancer	0.000571	0.000614	CcSEcCtD
Rizatriptan—Anxiety—Paclitaxel—kidney cancer	0.000569	0.000612	CcSEcCtD
Rizatriptan—Face oedema—Doxorubicin—kidney cancer	0.000569	0.000612	CcSEcCtD
Rizatriptan—Decreased appetite—Gemcitabine—kidney cancer	0.000568	0.000611	CcSEcCtD
Rizatriptan—Hypersensitivity—Dactinomycin—kidney cancer	0.000568	0.000611	CcSEcCtD
Rizatriptan—Chills—Capecitabine—kidney cancer	0.000567	0.00061	CcSEcCtD
Rizatriptan—Arrhythmia—Capecitabine—kidney cancer	0.000565	0.000608	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000564	0.000607	CcSEcCtD
Rizatriptan—Discomfort—Paclitaxel—kidney cancer	0.000564	0.000607	CcSEcCtD
Rizatriptan—Fatigue—Gemcitabine—kidney cancer	0.000564	0.000606	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Vincristine—kidney cancer	0.000563	0.000606	CcSEcCtD
Rizatriptan—Dizziness—Sorafenib—kidney cancer	0.00056	0.000602	CcSEcCtD
Rizatriptan—Pain—Gemcitabine—kidney cancer	0.000559	0.000601	CcSEcCtD
Rizatriptan—Constipation—Gemcitabine—kidney cancer	0.000559	0.000601	CcSEcCtD
Rizatriptan—Nausea—Erlotinib—kidney cancer	0.000559	0.000601	CcSEcCtD
Rizatriptan—Dry mouth—Paclitaxel—kidney cancer	0.000558	0.000601	CcSEcCtD
Rizatriptan—Diarrhoea—Sunitinib—kidney cancer	0.000557	0.0006	CcSEcCtD
Rizatriptan—Ataxia—Doxorubicin—kidney cancer	0.000554	0.000596	CcSEcCtD
Rizatriptan—Mental disorder—Capecitabine—kidney cancer	0.000554	0.000596	CcSEcCtD
Rizatriptan—Asthenia—Dactinomycin—kidney cancer	0.000553	0.000595	CcSEcCtD
Rizatriptan—Confusional state—Paclitaxel—kidney cancer	0.000552	0.000594	CcSEcCtD
Rizatriptan—Erythema—Capecitabine—kidney cancer	0.00055	0.000592	CcSEcCtD
Rizatriptan—Dehydration—Doxorubicin—kidney cancer	0.000548	0.000589	CcSEcCtD
Rizatriptan—Oedema—Paclitaxel—kidney cancer	0.000547	0.000589	CcSEcCtD
Rizatriptan—Anaphylactic shock—Paclitaxel—kidney cancer	0.000547	0.000589	CcSEcCtD
Rizatriptan—Abdominal pain—Vincristine—kidney cancer	0.000545	0.000586	CcSEcCtD
Rizatriptan—Body temperature increased—Vincristine—kidney cancer	0.000545	0.000586	CcSEcCtD
Rizatriptan—Flatulence—Capecitabine—kidney cancer	0.000542	0.000583	CcSEcCtD
Rizatriptan—Dysgeusia—Capecitabine—kidney cancer	0.000539	0.00058	CcSEcCtD
Rizatriptan—Dizziness—Sunitinib—kidney cancer	0.000539	0.00058	CcSEcCtD
Rizatriptan—Feeling abnormal—Gemcitabine—kidney cancer	0.000539	0.000579	CcSEcCtD
Rizatriptan—Shock—Paclitaxel—kidney cancer	0.000538	0.000579	CcSEcCtD
Rizatriptan—Vomiting—Sorafenib—kidney cancer	0.000538	0.000579	CcSEcCtD
Rizatriptan—Nervous system disorder—Paclitaxel—kidney cancer	0.000537	0.000577	CcSEcCtD
Rizatriptan—Tachycardia—Paclitaxel—kidney cancer	0.000534	0.000575	CcSEcCtD
Rizatriptan—Rash—Sorafenib—kidney cancer	0.000534	0.000574	CcSEcCtD
Rizatriptan—Dermatitis—Sorafenib—kidney cancer	0.000533	0.000574	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00053	0.000571	CcSEcCtD
Rizatriptan—Headache—Sorafenib—kidney cancer	0.00053	0.000571	CcSEcCtD
Rizatriptan—Muscle spasms—Capecitabine—kidney cancer	0.000529	0.000569	CcSEcCtD
Rizatriptan—Hyperhidrosis—Paclitaxel—kidney cancer	0.000529	0.000569	CcSEcCtD
Rizatriptan—Diarrhoea—Dactinomycin—kidney cancer	0.000528	0.000568	CcSEcCtD
Rizatriptan—Nasopharyngitis—Doxorubicin—kidney cancer	0.000527	0.000567	CcSEcCtD
Rizatriptan—Anorexia—Paclitaxel—kidney cancer	0.000522	0.000561	CcSEcCtD
Rizatriptan—Gastritis—Doxorubicin—kidney cancer	0.000521	0.000561	CcSEcCtD
Rizatriptan—Muscular weakness—Doxorubicin—kidney cancer	0.00052	0.000559	CcSEcCtD
Rizatriptan—Vision blurred—Capecitabine—kidney cancer	0.000519	0.000558	CcSEcCtD
Rizatriptan—Vomiting—Sunitinib—kidney cancer	0.000518	0.000557	CcSEcCtD
Rizatriptan—Body temperature increased—Gemcitabine—kidney cancer	0.000517	0.000556	CcSEcCtD
Rizatriptan—Tremor—Capecitabine—kidney cancer	0.000516	0.000555	CcSEcCtD
Rizatriptan—Rash—Sunitinib—kidney cancer	0.000514	0.000553	CcSEcCtD
Rizatriptan—Dermatitis—Sunitinib—kidney cancer	0.000513	0.000552	CcSEcCtD
Rizatriptan—Abdominal distension—Doxorubicin—kidney cancer	0.000513	0.000551	CcSEcCtD
Rizatriptan—Headache—Sunitinib—kidney cancer	0.00051	0.000549	CcSEcCtD
Rizatriptan—Dysphagia—Doxorubicin—kidney cancer	0.000509	0.000548	CcSEcCtD
Rizatriptan—Hypersensitivity—Vincristine—kidney cancer	0.000508	0.000546	CcSEcCtD
Rizatriptan—Nausea—Sorafenib—kidney cancer	0.000503	0.000541	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000499	0.000536	CcSEcCtD
Rizatriptan—Angina pectoris—Doxorubicin—kidney cancer	0.000496	0.000533	CcSEcCtD
Rizatriptan—Insomnia—Paclitaxel—kidney cancer	0.000495	0.000533	CcSEcCtD
Rizatriptan—Vertigo—Capecitabine—kidney cancer	0.000494	0.000532	CcSEcCtD
Rizatriptan—Asthenia—Vincristine—kidney cancer	0.000494	0.000532	CcSEcCtD
Rizatriptan—Syncope—Capecitabine—kidney cancer	0.000494	0.000531	CcSEcCtD
Rizatriptan—Paraesthesia—Paclitaxel—kidney cancer	0.000491	0.000529	CcSEcCtD
Rizatriptan—Vomiting—Dactinomycin—kidney cancer	0.00049	0.000528	CcSEcCtD
Rizatriptan—Dyspnoea—Paclitaxel—kidney cancer	0.000488	0.000525	CcSEcCtD
Rizatriptan—Somnolence—Paclitaxel—kidney cancer	0.000487	0.000523	CcSEcCtD
Rizatriptan—Palpitations—Capecitabine—kidney cancer	0.000486	0.000523	CcSEcCtD
Rizatriptan—Rash—Dactinomycin—kidney cancer	0.000486	0.000523	CcSEcCtD
Rizatriptan—Nausea—Sunitinib—kidney cancer	0.000484	0.000521	CcSEcCtD
Rizatriptan—Loss of consciousness—Capecitabine—kidney cancer	0.000484	0.00052	CcSEcCtD
Rizatriptan—Dyspepsia—Paclitaxel—kidney cancer	0.000482	0.000518	CcSEcCtD
Rizatriptan—Cough—Capecitabine—kidney cancer	0.00048	0.000517	CcSEcCtD
Rizatriptan—Dysuria—Doxorubicin—kidney cancer	0.000476	0.000512	CcSEcCtD
Rizatriptan—Decreased appetite—Paclitaxel—kidney cancer	0.000476	0.000512	CcSEcCtD
Rizatriptan—Hypertension—Capecitabine—kidney cancer	0.000475	0.000511	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000473	0.000509	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000473	0.000508	CcSEcCtD
Rizatriptan—Fatigue—Paclitaxel—kidney cancer	0.000472	0.000508	CcSEcCtD
Rizatriptan—Diarrhoea—Vincristine—kidney cancer	0.000471	0.000507	CcSEcCtD
Rizatriptan—Pollakiuria—Doxorubicin—kidney cancer	0.00047	0.000506	CcSEcCtD
Rizatriptan—Asthenia—Gemcitabine—kidney cancer	0.000469	0.000505	CcSEcCtD
Rizatriptan—Chest pain—Capecitabine—kidney cancer	0.000469	0.000504	CcSEcCtD
Rizatriptan—Arthralgia—Capecitabine—kidney cancer	0.000469	0.000504	CcSEcCtD
Rizatriptan—Myalgia—Capecitabine—kidney cancer	0.000469	0.000504	CcSEcCtD
Rizatriptan—Constipation—Paclitaxel—kidney cancer	0.000468	0.000503	CcSEcCtD
Rizatriptan—Pain—Paclitaxel—kidney cancer	0.000468	0.000503	CcSEcCtD
Rizatriptan—Anxiety—Capecitabine—kidney cancer	0.000467	0.000502	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000465	0.0005	CcSEcCtD
Rizatriptan—Discomfort—Capecitabine—kidney cancer	0.000463	0.000498	CcSEcCtD
Rizatriptan—Pruritus—Gemcitabine—kidney cancer	0.000462	0.000498	CcSEcCtD
Rizatriptan—Dry mouth—Capecitabine—kidney cancer	0.000458	0.000493	CcSEcCtD
Rizatriptan—Nausea—Dactinomycin—kidney cancer	0.000458	0.000493	CcSEcCtD
Rizatriptan—Dizziness—Vincristine—kidney cancer	0.000456	0.00049	CcSEcCtD
Rizatriptan—Confusional state—Capecitabine—kidney cancer	0.000453	0.000487	CcSEcCtD
Rizatriptan—Feeling abnormal—Paclitaxel—kidney cancer	0.000451	0.000485	CcSEcCtD
Rizatriptan—Oedema—Capecitabine—kidney cancer	0.000449	0.000483	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000448	0.000481	CcSEcCtD
Rizatriptan—Diarrhoea—Gemcitabine—kidney cancer	0.000447	0.000481	CcSEcCtD
Rizatriptan—Shock—Capecitabine—kidney cancer	0.000442	0.000475	CcSEcCtD
Rizatriptan—Nervous system disorder—Capecitabine—kidney cancer	0.00044	0.000474	CcSEcCtD
Rizatriptan—Tachycardia—Capecitabine—kidney cancer	0.000438	0.000472	CcSEcCtD
Rizatriptan—Vomiting—Vincristine—kidney cancer	0.000438	0.000471	CcSEcCtD
Rizatriptan—Sweating—Doxorubicin—kidney cancer	0.000435	0.000468	CcSEcCtD
Rizatriptan—Urticaria—Paclitaxel—kidney cancer	0.000435	0.000468	CcSEcCtD
Rizatriptan—Rash—Vincristine—kidney cancer	0.000434	0.000467	CcSEcCtD
Rizatriptan—Hyperhidrosis—Capecitabine—kidney cancer	0.000434	0.000467	CcSEcCtD
Rizatriptan—Dermatitis—Vincristine—kidney cancer	0.000434	0.000467	CcSEcCtD
Rizatriptan—Abdominal pain—Paclitaxel—kidney cancer	0.000433	0.000465	CcSEcCtD
Rizatriptan—Body temperature increased—Paclitaxel—kidney cancer	0.000433	0.000465	CcSEcCtD
Rizatriptan—Headache—Vincristine—kidney cancer	0.000432	0.000464	CcSEcCtD
Rizatriptan—Epistaxis—Doxorubicin—kidney cancer	0.000428	0.000461	CcSEcCtD
Rizatriptan—Anorexia—Capecitabine—kidney cancer	0.000428	0.000461	CcSEcCtD
Rizatriptan—Vomiting—Gemcitabine—kidney cancer	0.000416	0.000447	CcSEcCtD
Rizatriptan—Bradycardia—Doxorubicin—kidney cancer	0.000415	0.000446	CcSEcCtD
Rizatriptan—Rash—Gemcitabine—kidney cancer	0.000412	0.000443	CcSEcCtD
Rizatriptan—Dermatitis—Gemcitabine—kidney cancer	0.000412	0.000443	CcSEcCtD
Rizatriptan—Headache—Gemcitabine—kidney cancer	0.00041	0.000441	CcSEcCtD
Rizatriptan—Nausea—Vincristine—kidney cancer	0.000409	0.00044	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000409	0.00044	CcSEcCtD
Rizatriptan—Insomnia—Capecitabine—kidney cancer	0.000406	0.000437	CcSEcCtD
Rizatriptan—Hypoaesthesia—Doxorubicin—kidney cancer	0.000405	0.000436	CcSEcCtD
Rizatriptan—Pharyngitis—Doxorubicin—kidney cancer	0.000404	0.000435	CcSEcCtD
Rizatriptan—Paraesthesia—Capecitabine—kidney cancer	0.000403	0.000434	CcSEcCtD
Rizatriptan—Hypersensitivity—Paclitaxel—kidney cancer	0.000403	0.000434	CcSEcCtD
Rizatriptan—Dyspnoea—Capecitabine—kidney cancer	0.0004	0.000431	CcSEcCtD
Rizatriptan—Dyspepsia—Capecitabine—kidney cancer	0.000395	0.000425	CcSEcCtD
Rizatriptan—Asthenia—Paclitaxel—kidney cancer	0.000393	0.000422	CcSEcCtD
Rizatriptan—Decreased appetite—Capecitabine—kidney cancer	0.00039	0.00042	CcSEcCtD
Rizatriptan—Nausea—Gemcitabine—kidney cancer	0.000388	0.000418	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000388	0.000417	CcSEcCtD
Rizatriptan—Fatigue—Capecitabine—kidney cancer	0.000387	0.000417	CcSEcCtD
Rizatriptan—Pruritus—Paclitaxel—kidney cancer	0.000387	0.000417	CcSEcCtD
Rizatriptan—Pain—Capecitabine—kidney cancer	0.000384	0.000413	CcSEcCtD
Rizatriptan—Constipation—Capecitabine—kidney cancer	0.000384	0.000413	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—kidney cancer	0.00038	0.000409	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—kidney cancer	0.000378	0.000407	CcSEcCtD
Rizatriptan—Diarrhoea—Paclitaxel—kidney cancer	0.000374	0.000403	CcSEcCtD
Rizatriptan—Feeling abnormal—Capecitabine—kidney cancer	0.00037	0.000398	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—kidney cancer	0.00037	0.000398	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Capecitabine—kidney cancer	0.000367	0.000395	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—kidney cancer	0.000366	0.000393	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—kidney cancer	0.000364	0.000392	CcSEcCtD
Rizatriptan—Dizziness—Paclitaxel—kidney cancer	0.000362	0.000389	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—kidney cancer	0.000357	0.000384	CcSEcCtD
Rizatriptan—Urticaria—Capecitabine—kidney cancer	0.000357	0.000384	CcSEcCtD
Rizatriptan—Abdominal pain—Capecitabine—kidney cancer	0.000355	0.000382	CcSEcCtD
Rizatriptan—Body temperature increased—Capecitabine—kidney cancer	0.000355	0.000382	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—kidney cancer	0.000355	0.000382	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—kidney cancer	0.00035	0.000376	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—kidney cancer	0.000348	0.000374	CcSEcCtD
Rizatriptan—Vomiting—Paclitaxel—kidney cancer	0.000348	0.000374	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—kidney cancer	0.000347	0.000374	CcSEcCtD
Rizatriptan—Rash—Paclitaxel—kidney cancer	0.000345	0.000371	CcSEcCtD
Rizatriptan—Dermatitis—Paclitaxel—kidney cancer	0.000345	0.000371	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—kidney cancer	0.000345	0.000371	CcSEcCtD
Rizatriptan—Headache—Paclitaxel—kidney cancer	0.000343	0.000369	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—kidney cancer	0.000341	0.000367	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—kidney cancer	0.000334	0.00036	CcSEcCtD
Rizatriptan—Hypersensitivity—Capecitabine—kidney cancer	0.000331	0.000356	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—kidney cancer	0.000326	0.000351	CcSEcCtD
Rizatriptan—Nausea—Paclitaxel—kidney cancer	0.000325	0.00035	CcSEcCtD
Rizatriptan—Asthenia—Capecitabine—kidney cancer	0.000322	0.000347	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—kidney cancer	0.000319	0.000343	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—kidney cancer	0.000318	0.000342	CcSEcCtD
Rizatriptan—Pruritus—Capecitabine—kidney cancer	0.000318	0.000342	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—kidney cancer	0.000313	0.000337	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—kidney cancer	0.000312	0.000335	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—kidney cancer	0.00031	0.000333	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—kidney cancer	0.000307	0.000331	CcSEcCtD
Rizatriptan—Diarrhoea—Capecitabine—kidney cancer	0.000307	0.000331	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—kidney cancer	0.000306	0.000329	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—kidney cancer	0.000302	0.000325	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—kidney cancer	0.000302	0.000325	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—kidney cancer	0.000302	0.000325	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—kidney cancer	0.000301	0.000324	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—kidney cancer	0.000298	0.000321	CcSEcCtD
Rizatriptan—Dizziness—Capecitabine—kidney cancer	0.000297	0.00032	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—kidney cancer	0.000295	0.000318	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—kidney cancer	0.000292	0.000314	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—kidney cancer	0.00029	0.000311	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—kidney cancer	0.00029	0.000311	CcSEcCtD
Rizatriptan—Vomiting—Capecitabine—kidney cancer	0.000286	0.000307	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—kidney cancer	0.000285	0.000306	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—kidney cancer	0.000284	0.000305	CcSEcCtD
Rizatriptan—Rash—Capecitabine—kidney cancer	0.000283	0.000305	CcSEcCtD
Rizatriptan—Dermatitis—Capecitabine—kidney cancer	0.000283	0.000304	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—kidney cancer	0.000283	0.000304	CcSEcCtD
Rizatriptan—Headache—Capecitabine—kidney cancer	0.000281	0.000303	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—kidney cancer	0.00028	0.000301	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—kidney cancer	0.000276	0.000297	CcSEcCtD
Rizatriptan—Nausea—Capecitabine—kidney cancer	0.000267	0.000287	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000264	0.000284	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—kidney cancer	0.000262	0.000282	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—kidney cancer	0.00026	0.00028	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—kidney cancer	0.000258	0.000278	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—kidney cancer	0.000257	0.000277	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—kidney cancer	0.000255	0.000274	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—kidney cancer	0.000252	0.000271	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00025	0.000269	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—kidney cancer	0.00025	0.000269	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—kidney cancer	0.000248	0.000266	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—kidney cancer	0.000248	0.000266	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—kidney cancer	0.000239	0.000257	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000237	0.000255	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—kidney cancer	0.00023	0.000247	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—kidney cancer	0.000229	0.000246	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—kidney cancer	0.000229	0.000246	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—kidney cancer	0.000213	0.000229	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—kidney cancer	0.000208	0.000223	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—kidney cancer	0.000205	0.00022	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—kidney cancer	0.000198	0.000213	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—kidney cancer	0.000191	0.000206	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—kidney cancer	0.000184	0.000198	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—kidney cancer	0.000183	0.000196	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—kidney cancer	0.000182	0.000196	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—kidney cancer	0.000181	0.000195	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—kidney cancer	0.000172	0.000185	CcSEcCtD
Rizatriptan—HTR1B—Signaling Pathways—CASP2—kidney cancer	5.17e-05	0.00104	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CRABP1—kidney cancer	5.06e-05	0.00102	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACY1—kidney cancer	4.92e-05	0.000994	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SFRP2—kidney cancer	4.88e-05	0.000987	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—POMC—kidney cancer	4.87e-05	0.000986	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GRB7—kidney cancer	4.82e-05	0.000975	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ANXA1—kidney cancer	4.75e-05	0.00096	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GRB7—kidney cancer	4.72e-05	0.000955	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ITPR2—kidney cancer	4.71e-05	0.000952	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—POMC—kidney cancer	4.53e-05	0.000916	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ITPR2—kidney cancer	4.49e-05	0.000907	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ITPR2—kidney cancer	4.39e-05	0.000888	CbGpPWpGaD
Rizatriptan—MAOA—Neuronal System—MAPK1—kidney cancer	4.34e-05	0.000877	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF2—kidney cancer	4.31e-05	0.000872	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN2B—kidney cancer	4.3e-05	0.000868	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTT1—kidney cancer	4.29e-05	0.000868	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ACHE—kidney cancer	4.29e-05	0.000868	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.19e-05	0.000848	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PDHB—kidney cancer	4.18e-05	0.000845	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1R—kidney cancer	4.17e-05	0.000843	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—POMC—kidney cancer	4.17e-05	0.000843	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNA1—kidney cancer	4.07e-05	0.000822	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SCARB1—kidney cancer	4.06e-05	0.000821	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EIF4EBP1—kidney cancer	4.04e-05	0.000817	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HSPB1—kidney cancer	4.04e-05	0.000817	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS1—kidney cancer	4.02e-05	0.000813	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—RAF1—kidney cancer	4.02e-05	0.000813	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNA1—kidney cancer	3.98e-05	0.000805	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—IL2—kidney cancer	3.97e-05	0.000802	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EIF4EBP1—kidney cancer	3.96e-05	0.0008	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HSPB1—kidney cancer	3.96e-05	0.0008	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PSMD7—kidney cancer	3.94e-05	0.000797	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKAP13—kidney cancer	3.93e-05	0.000795	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP2—kidney cancer	3.93e-05	0.000795	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CCBL1—kidney cancer	3.93e-05	0.000795	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ANXA1—kidney cancer	3.76e-05	0.00076	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PSMD7—kidney cancer	3.76e-05	0.00076	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TSC1—kidney cancer	3.76e-05	0.00076	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—BCHE—kidney cancer	3.74e-05	0.000756	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SLC5A5—kidney cancer	3.69e-05	0.000747	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PSMD7—kidney cancer	3.68e-05	0.000744	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TSC1—kidney cancer	3.68e-05	0.000744	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ANXA1—kidney cancer	3.68e-05	0.000744	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FLT1—kidney cancer	3.64e-05	0.000736	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL2—kidney cancer	3.6e-05	0.000729	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GRB7—kidney cancer	3.6e-05	0.000728	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—SLC2A1—kidney cancer	3.57e-05	0.000721	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FLT1—kidney cancer	3.56e-05	0.000721	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.55e-05	0.000719	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HIF1A—kidney cancer	3.43e-05	0.000694	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—POMC—kidney cancer	3.43e-05	0.000694	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TSC2—kidney cancer	3.43e-05	0.000693	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPAT—kidney cancer	3.41e-05	0.000689	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.41e-05	0.000689	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PAK1—kidney cancer	3.37e-05	0.000682	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUNB—kidney cancer	3.37e-05	0.000682	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.36e-05	0.00068	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—POMC—kidney cancer	3.36e-05	0.00068	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ITPR2—kidney cancer	3.35e-05	0.000676	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.33e-05	0.000673	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUNB—kidney cancer	3.3e-05	0.000668	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PAK1—kidney cancer	3.3e-05	0.000668	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KDR—kidney cancer	3.28e-05	0.000664	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—FH—kidney cancer	3.17e-05	0.000641	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APRT—kidney cancer	3.17e-05	0.000641	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—POMC—kidney cancer	3.12e-05	0.00063	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.1e-05	0.000626	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—POMC—kidney cancer	3.05e-05	0.000617	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNA1—kidney cancer	3.03e-05	0.000613	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KIT—kidney cancer	3.03e-05	0.000612	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—APC—kidney cancer	3.03e-05	0.000612	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EIF4EBP1—kidney cancer	3.02e-05	0.00061	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HSPB1—kidney cancer	3.02e-05	0.00061	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPC3—kidney cancer	2.98e-05	0.000602	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTP1—kidney cancer	2.98e-05	0.000601	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA2—kidney cancer	2.9e-05	0.000586	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—MAPK3—kidney cancer	2.9e-05	0.000586	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—POMC—kidney cancer	2.88e-05	0.000582	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—BRAF—kidney cancer	2.84e-05	0.000575	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALAD—kidney cancer	2.82e-05	0.000571	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCB1—kidney cancer	2.82e-05	0.000569	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSMD7—kidney cancer	2.8e-05	0.000567	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSC1—kidney cancer	2.8e-05	0.000567	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ANXA1—kidney cancer	2.8e-05	0.000567	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF2—kidney cancer	2.76e-05	0.000558	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—MAPK1—kidney cancer	2.76e-05	0.000557	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.76e-05	0.000557	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN2B—kidney cancer	2.75e-05	0.000555	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTM1—kidney cancer	2.73e-05	0.000553	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FLT1—kidney cancer	2.72e-05	0.000549	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF2—kidney cancer	2.7e-05	0.000546	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.69e-05	0.000545	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN2B—kidney cancer	2.69e-05	0.000544	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1R—kidney cancer	2.67e-05	0.000539	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—PIK3CA—kidney cancer	2.63e-05	0.000533	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1R—kidney cancer	2.61e-05	0.000528	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—KRAS—kidney cancer	2.6e-05	0.000526	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP1A1—kidney cancer	2.59e-05	0.000524	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.58e-05	0.000522	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PGK1—kidney cancer	2.58e-05	0.000522	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—RAF1—kidney cancer	2.57e-05	0.00052	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—POMC—kidney cancer	2.56e-05	0.000518	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—IL2—kidney cancer	2.54e-05	0.000513	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LDHB—kidney cancer	2.53e-05	0.000512	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUNB—kidney cancer	2.52e-05	0.000509	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PAK1—kidney cancer	2.52e-05	0.000509	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—RAF1—kidney cancer	2.52e-05	0.000509	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—IL2—kidney cancer	2.48e-05	0.000502	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—PIK3CA—kidney cancer	2.39e-05	0.000484	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RAF1—kidney cancer	2.37e-05	0.00048	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RELA—kidney cancer	2.36e-05	0.000478	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ERBB2—kidney cancer	2.35e-05	0.000475	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—POMC—kidney cancer	2.33e-05	0.00047	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MTOR—kidney cancer	2.32e-05	0.000469	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL2—kidney cancer	2.3e-05	0.000466	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL2—kidney cancer	2.26e-05	0.000456	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA9—kidney cancer	2.2e-05	0.000444	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—kidney cancer	2.2e-05	0.000444	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TSC2—kidney cancer	2.19e-05	0.000443	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1B—kidney cancer	2.18e-05	0.00044	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—kidney cancer	2.15e-05	0.000435	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.15e-05	0.000434	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TSC2—kidney cancer	2.14e-05	0.000434	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL2—kidney cancer	2.13e-05	0.00043	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—kidney cancer	2.1e-05	0.000425	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCND1—kidney cancer	2.08e-05	0.00042	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—JUN—kidney cancer	2.07e-05	0.000419	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF2—kidney cancer	2.06e-05	0.000416	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—kidney cancer	2.06e-05	0.000416	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CTNNB1—kidney cancer	2.06e-05	0.000415	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN2B—kidney cancer	2.05e-05	0.000414	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTEN—kidney cancer	2e-05	0.000405	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1R—kidney cancer	1.99e-05	0.000402	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIT—kidney cancer	1.93e-05	0.000391	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APC—kidney cancer	1.93e-05	0.000391	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—kidney cancer	1.93e-05	0.000391	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—RAF1—kidney cancer	1.92e-05	0.000388	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APC—kidney cancer	1.89e-05	0.000383	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIT—kidney cancer	1.89e-05	0.000383	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—kidney cancer	1.89e-05	0.000383	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CRABP1—kidney cancer	1.87e-05	0.000378	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK3—kidney cancer	1.85e-05	0.000375	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—kidney cancer	1.84e-05	0.000372	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—kidney cancer	1.82e-05	0.000368	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK3—kidney cancer	1.81e-05	0.000367	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—kidney cancer	1.81e-05	0.000366	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—kidney cancer	1.8e-05	0.000365	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—kidney cancer	1.78e-05	0.00036	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK1—kidney cancer	1.76e-05	0.000356	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ITPR2—kidney cancer	1.74e-05	0.000351	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK1—kidney cancer	1.73e-05	0.000349	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—kidney cancer	1.72e-05	0.000348	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK3—kidney cancer	1.71e-05	0.000346	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—kidney cancer	1.68e-05	0.000341	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—kidney cancer	1.66e-05	0.000337	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—kidney cancer	1.66e-05	0.000337	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—kidney cancer	1.65e-05	0.000333	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—kidney cancer	1.64e-05	0.000331	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TSC2—kidney cancer	1.63e-05	0.00033	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—kidney cancer	1.63e-05	0.00033	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK1—kidney cancer	1.63e-05	0.000329	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.6e-05	0.000324	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACHE—kidney cancer	1.58e-05	0.00032	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—kidney cancer	1.58e-05	0.00032	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—kidney cancer	1.57e-05	0.000317	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—kidney cancer	1.54e-05	0.000312	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—kidney cancer	1.54e-05	0.000311	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—kidney cancer	1.53e-05	0.000309	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAF1—kidney cancer	1.52e-05	0.000307	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RELA—kidney cancer	1.51e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB2—kidney cancer	1.5e-05	0.000304	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SCARB1—kidney cancer	1.5e-05	0.000303	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—kidney cancer	1.5e-05	0.000303	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAF1—kidney cancer	1.49e-05	0.000301	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS1—kidney cancer	1.48e-05	0.0003	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MTOR—kidney cancer	1.48e-05	0.0003	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RELA—kidney cancer	1.48e-05	0.000299	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB2—kidney cancer	1.47e-05	0.000297	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSMD7—kidney cancer	1.45e-05	0.000294	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MTOR—kidney cancer	1.45e-05	0.000293	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APC—kidney cancer	1.44e-05	0.000292	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIT—kidney cancer	1.44e-05	0.000292	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—kidney cancer	1.41e-05	0.000286	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1B—kidney cancer	1.39e-05	0.000281	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK3—kidney cancer	1.38e-05	0.000279	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BCHE—kidney cancer	1.38e-05	0.000279	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—kidney cancer	1.37e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—kidney cancer	1.37e-05	0.000276	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.36e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1B—kidney cancer	1.36e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—kidney cancer	1.36e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—kidney cancer	1.36e-05	0.000274	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—kidney cancer	1.34e-05	0.000272	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—kidney cancer	1.33e-05	0.000269	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—kidney cancer	1.33e-05	0.000268	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUN—kidney cancer	1.32e-05	0.000268	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.32e-05	0.000266	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK1—kidney cancer	1.31e-05	0.000266	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNB1—kidney cancer	1.31e-05	0.000266	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—kidney cancer	1.3e-05	0.000263	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUN—kidney cancer	1.3e-05	0.000262	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNB1—kidney cancer	1.29e-05	0.00026	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—kidney cancer	1.28e-05	0.000259	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.28e-05	0.000258	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—kidney cancer	1.26e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—kidney cancer	1.25e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—kidney cancer	1.24e-05	0.000251	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—kidney cancer	1.16e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	1.14e-05	0.000231	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—kidney cancer	1.13e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAF1—kidney cancer	1.13e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RELA—kidney cancer	1.13e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB2—kidney cancer	1.12e-05	0.000227	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.11e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MTOR—kidney cancer	1.11e-05	0.000224	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—kidney cancer	1.1e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK3—kidney cancer	1.09e-05	0.000221	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK3—kidney cancer	1.07e-05	0.000217	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—kidney cancer	1.06e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—kidney cancer	1.04e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK1—kidney cancer	1.04e-05	0.000211	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—kidney cancer	1.04e-05	0.00021	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	1.04e-05	0.00021	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK1—kidney cancer	1.02e-05	0.000206	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—kidney cancer	1.02e-05	0.000205	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—kidney cancer	1.01e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—kidney cancer	9.9e-06	0.0002	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUN—kidney cancer	9.88e-06	0.0002	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—kidney cancer	9.84e-06	0.000199	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	9.8e-06	0.000198	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—kidney cancer	9.63e-06	0.000195	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1A1—kidney cancer	9.56e-06	0.000193	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—kidney cancer	9.55e-06	0.000193	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—kidney cancer	9.48e-06	0.000192	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	9.04e-06	0.000183	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	8.85e-06	0.000179	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—kidney cancer	8.74e-06	0.000177	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—kidney cancer	8.63e-06	0.000174	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—kidney cancer	8.56e-06	0.000173	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK3—kidney cancer	8.16e-06	0.000165	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—kidney cancer	7.94e-06	0.000161	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.85e-06	0.000159	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK1—kidney cancer	7.77e-06	0.000157	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—kidney cancer	7.34e-06	0.000148	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—kidney cancer	7.13e-06	0.000144	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	6.74e-06	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—kidney cancer	6.52e-06	0.000132	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—kidney cancer	5.68e-06	0.000115	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—kidney cancer	4.96e-06	0.0001	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.5e-06	7.07e-05	CbGpPWpGaD
